(redirected from Piperacillin-tazobactam)
Also found in: Thesaurus, Medical.
Related to Piperacillin-tazobactam: Tazocin, Zosyn


A semisynthetic broad-spectrum penicillin, C23H27N5O7S, used in its sodium form often in combination with the beta-lactamase inhibitor tazobactam, and active against a variety of gram-positive and gram-negative bacteria.

ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.piperacillin - a synthetic type of penicillin antibiotic (trade name Pipracil) used for moderate to severe infections
penicillin - any of various antibiotics obtained from Penicillium molds (or produced synthetically) and used in the treatment of various infections and diseases
References in periodicals archive ?
The Targeting Antibiotic Non-susceptible Gram-negative Organisms, or TANGO 1, trial was the pivotal Phase 3 study that compared the efficacy and safety of Vabomere to piperacillin-tazobactam in the treatment of patients with cUTI and acute pyelonephritis.
The FDA approval of Vabomere was supported by TANGO-1, a Phase III, multi-center, randomized, double-blind, double-dummy study to evaluate the efficacy, safety and tolerability of Vabomere compared to piperacillin-tazobactam in the treatment of cUTI, including acute pyelonephritis, in adults.
None of the isolates showed resistance to cefoperazone-sulbactam, imipenem, piperacillin-tazobactam and amikacin.
Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
For Gram-negative bacilli ampicillin, cefixime, ceftriaxone, cotrimoxazole, ciprofloxacin, ofloxacin, gentamicin, amikacin, amoxicillin-clavulanic acid, cefoperazone-sulbactam, piperacillin-tazobactam, and Imipenem were used.
Contract notice: Supply antibiotics (linezolid, piperacillin-tazobactam and meropenem).
putida sensitive to cefepime, gentamycin, ciprofloxacin, and amikacin, but resistant to meropenem and piperacillin-tazobactam.
Carbavance demonstrated statistical superiority over piperacillin-tazobactam with overall success in 98.
The top 10 antimicrobials they reported as being in short supply were piperacillin-tazobactam, ampicillin-sulbactam, meropenem, cefotaxime, cefepime, trimethoprim-sulfamethoxazole (TMP-SMX), doxycycline, imipenem, acyclovir, and amikacin.
One log2 dilution of the breakpoints was 62% for ceftazidime, and 59% for piperacillin-tazobactam (Sader et al.